BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23651192)

  • 1. Molecular programming of steady-state dendritic cells: impact on autoimmunity and tumor immune surveillance.
    Johnson DJ; Ohashi PS
    Ann N Y Acad Sci; 2013 May; 1284():46-51. PubMed ID: 23651192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of tolerogenic dendritic cells by NF-κB blockade and Fcγ receptor modulation.
    Carreño LJ; Riedel CA; Kalergis AM
    Methods Mol Biol; 2011; 677():339-53. PubMed ID: 20941620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homeostatic NF-κB Signaling in Steady-State Migratory Dendritic Cells Regulates Immune Homeostasis and Tolerance.
    Baratin M; Foray C; Demaria O; Habbeddine M; Pollet E; Maurizio J; Verthuy C; Davanture S; Azukizawa H; Flores-Langarica A; Dalod M; Lawrence T
    Immunity; 2015 Apr; 42(4):627-39. PubMed ID: 25862089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of nuclear factor-kappa B enhances the capacity of immature dendritic cells to induce antigen-specific tolerance in experimental autoimmune encephalomyelitis.
    Iruretagoyena MI; Sepúlveda SE; Lezana JP; Hermoso M; Bronfman M; Gutiérrez MA; Jacobelli SH; Kalergis AM
    J Pharmacol Exp Ther; 2006 Jul; 318(1):59-67. PubMed ID: 16597709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-host immune interactions and dendritic cell dysfunction.
    Yang L; Carbone DP
    Adv Cancer Res; 2004; 92():13-27. PubMed ID: 15530555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cells ameliorate autoimmunity in the CNS by controlling the homeostasis of PD-1 receptor(+) regulatory T cells.
    Yogev N; Frommer F; Lukas D; Kautz-Neu K; Karram K; Ielo D; von Stebut E; Probst HC; van den Broek M; Riethmacher D; Birnberg T; Blank T; Reizis B; Korn T; Wiendl H; Jung S; Prinz M; Kurschus FC; Waisman A
    Immunity; 2012 Aug; 37(2):264-75. PubMed ID: 22902234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presentation of self-antigens on MHC class II molecules during dendritic cell maturation.
    Zwickey HL; Unternaehrer JJ; Mellman I
    Int Immunol; 2006 Jan; 18(1):199-209. PubMed ID: 16361313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear factor-κB1 controls the functional maturation of dendritic cells and prevents the activation of autoreactive T cells.
    Dissanayake D; Hall H; Berg-Brown N; Elford AR; Hamilton SR; Murakami K; Deluca LS; Gommerman JL; Ohashi PS
    Nat Med; 2011 Nov; 17(12):1663-7. PubMed ID: 22081022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DCs in immune tolerance in steady-state conditions.
    Fukaya T; Takagi H; Taya H; Sato K
    Methods Mol Biol; 2011; 677():113-26. PubMed ID: 20941606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of costimulatory ligand CD70 on steady-state dendritic cells breaks CD8+ T cell tolerance and permits effective immunity.
    Keller AM; Schildknecht A; Xiao Y; van den Broek M; Borst J
    Immunity; 2008 Dec; 29(6):934-46. PubMed ID: 19062317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Balancing between immunity and tolerance: an interplay between dendritic cells, regulatory T cells, and effector T cells.
    Cools N; Ponsaerts P; Van Tendeloo VF; Berneman ZN
    J Leukoc Biol; 2007 Dec; 82(6):1365-74. PubMed ID: 17711977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerogenic dendritic cells for autoimmune disease and transplantation.
    Thomson AW; Robbins PD
    Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii90-6. PubMed ID: 19022823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 'kiss of death' by dendritic cells to cancer cells.
    Chan CW; Housseau F
    Cell Death Differ; 2008 Jan; 15(1):58-69. PubMed ID: 17948029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cells integrate signals from the tumor microenvironment to modulate immunity and tumor growth.
    Lin A; Schildknecht A; Nguyen LT; Ohashi PS
    Immunol Lett; 2010 Jan; 127(2):77-84. PubMed ID: 19778555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel findings in drug-induced dendritic cell tolerogenicity.
    Svajger U; Obermajer N; Jeras M
    Int Rev Immunol; 2010 Dec; 29(6):574-607. PubMed ID: 21073328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerogenic dendritic cells: key regulators of peripheral tolerance in health and disease.
    Saei A; Hadjati J
    Int Arch Allergy Immunol; 2013; 161(4):293-303. PubMed ID: 23689518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunobiology of dendritic cells and their application in clinical practice].
    Galamb O; Molnár B; Tulassay Z
    Orv Hetil; 2003 Sep; 144(38):1873-9. PubMed ID: 14596026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The regulatory role of dendritic cells in the induction and maintenance of T-cell tolerance.
    Zanoni I; Granucci F
    Autoimmunity; 2011 Feb; 44(1):23-32. PubMed ID: 20670116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cells and damage-associated molecular patterns: endogenous danger signals linking innate and adaptive immunity.
    Nace G; Evankovich J; Eid R; Tsung A
    J Innate Immun; 2012; 4(1):6-15. PubMed ID: 22086146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yin-Yang regulation of autoimmunity by DCs.
    't Hart BA; van Kooyk Y
    Trends Immunol; 2004 Jul; 25(7):353-9. PubMed ID: 15207502
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.